Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

As a group, these new medications are commonly referred to as "biologics" and represent the most current attempt to target specific steps in the immune mechanisms underlying psoriasis. It is the ...

Women with psoriasis show shorter drug survival for biologics, including IL-17/23 inhibitors, due to lower satisfaction and ...

Discover a study that assessed the risk of hospitalisation for serious infections based on different categories of systemic ...

A RECENT study has highlighted key biological and clinical factors linked to resistance to biologic therapies in patients ...

A panelist discusses how real-world evidence from a large cohort study (n = 31521) presented at AAD 2025 reveals notable ...

A decade-long study finds that obesity is associated with a significantly increased risk for biologic treatment failure in ...

Several characteristics, including BMI and Charlson Comorbidity Index, were associated with super response to biologics in patients with psoriasis.

Additionally, some infections may exacerbate or trigger psoriasis, such as strep throat. Regardless of whether you are on a biologic or immunosuppressive medication for psoriasis, it’s essential ...

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Biologics targeting interleukin-12, -23, and -17 were ...

These biologics may have important safety benefits for older adults with higher infection risk compared to other existing treatments. Psoriasis and psoriatic arthritis occur throughout adulthood ...